Novartis Pharma Stein AG (quality control (chemical/physical))

Ukraine

All drugs from this manufacturer

  • HYRIMOZ 40

    The drug is prescribed for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and uveitis.

    Dosage form: solution for injection

    Active substance Dosage
    adalimumab 40 mg/0.8 mL

    ATC: L04AB04